Literature DB >> 17225131

Value of MR phase-contrast flow measurements for functional assessment of pulmonary arterial hypertension.

Sebastian Ley1, Derliz Mereles, Michael Puderbach, Ekkehard Gruenig, Helena Schöck, Monika Eichinger, Julia Ley-Zaporozhan, Christian Fink, Hans-Ulrich Kauczor.   

Abstract

Goals of our study were to compare the pulmonary hemodynamics between healthy volunteers and patients with pulmonary arterial hypertension (PAH) and correlate MR flow measurements with echocardiography. Twenty-five patients with PAH and 25 volunteers were examined at 1.5 T. Phase-contrast flow measurements were performed in the ascending aorta and pulmonary trunk, resulting in the following parameters: peak velocity (cm/s), average blood flow (l/min), time to peak velocity (ms), velocity rise gradient and pulmonary distensibility (cm(2)). The bronchosystemic shunt was calculated. In PAH patients transthoracic echocardiography and right-heart catheterization (RHC) served as the gold standard. In comparison to volunteers, the PAH patients showed significantly reduced pulmonary velocities (P = 0.002), blood flow (P = 0.002) and pulmonary distensibility (P = 0.008). In patients, the time to peak velocity was shorter (P<0.001), and the velocity rise gradient was steeper (P = 0.002) than in volunteers. While in volunteers the peak velocity in the aorta was reached earlier, it was the reverse in patients. Patients showed a significant bronchosystemic shunt (P = 0.01). No meaningful correlation was found between MRI measurements and echocardiography or RHC. MRI is a feasible technique for the differentiation between PAH and volunteers. Further studies have to be conducted for the absolute calculation of pressure estimates.

Entities:  

Mesh:

Year:  2007        PMID: 17225131     DOI: 10.1007/s00330-006-0559-9

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  31 in total

1.  Pulmonary arterial resistance: noninvasive measurement with indexes of pulmonary flow estimated at velocity-encoded MR imaging--preliminary experience.

Authors:  E Mousseaux; J P Tasu; O Jolivet; G Simonneau; J Bittoun; J C Gaux
Journal:  Radiology       Date:  1999-09       Impact factor: 11.105

2.  Evaluation of left ventricular volumes and ejection fraction using fast steady-state cine MR imaging: comparison with left ventricular angiography.

Authors:  Yasutaka Ichikawa; Hajime Sakuma; Kakuya Kitagawa; Nanaka Ishida; Kan Takeda; Shoko Uemura; Munenobu Motoyasu; Takeshi Nakano; Atsushi Nozaki
Journal:  J Cardiovasc Magn Reson       Date:  2003       Impact factor: 5.364

3.  Chronic pulmonary embolism: combining MR angiography with functional assessment.

Authors:  Martin R Prince; Philip O Alderson; H Dirk Sostman
Journal:  Radiology       Date:  2004-08       Impact factor: 11.105

Review 4.  MR measurement of blood flow in the cardiovascular system.

Authors:  G H Mostbeck; G R Caputo; C B Higgins
Journal:  AJR Am J Roentgenol       Date:  1992-09       Impact factor: 3.959

5.  MRI Measurement of the hemodynamics of the pulmonary and systemic arterial circulation: influence of breathing maneuvers.

Authors:  Sebastian Ley; Christian Fink; Michael Puderbach; Julia Zaporozhan; Christian Plathow; Monika Eichinger; Waldemar Hosch; Karl-Friedrich Kreitner; Hans-Ulrich Kauczor
Journal:  AJR Am J Roentgenol       Date:  2006-08       Impact factor: 3.959

6.  Flow quantification using fast cine phase-contrast MR imaging, conventional cine phase-contrast MR imaging, and Doppler sonography: in vitro and in vivo validation.

Authors:  V S Lee; C E Spritzer; B A Carroll; L G Pool; M A Bernstein; S K Heinle; J R MacFall
Journal:  AJR Am J Roentgenol       Date:  1997-10       Impact factor: 3.959

7.  ACC/AHA Guidelines for the Clinical Application of Echocardiography. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Clinical Application of Echocardiography). Developed in collaboration with the American Society of Echocardiography.

Authors:  M D Cheitlin; J S Alpert; W F Armstrong; G P Aurigemma; G A Beller; F Z Bierman; T W Davidson; J L Davis; P S Douglas; L D Gillam
Journal:  Circulation       Date:  1997-03-18       Impact factor: 29.690

8.  Screening, early detection, and diagnosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines.

Authors:  Michael McGoon; David Gutterman; Virginia Steen; Robin Barst; Douglas C McCrory; Terry A Fortin; James E Loyd
Journal:  Chest       Date:  2004-07       Impact factor: 9.410

Review 9.  Diagnosis and differential assessment of pulmonary arterial hypertension.

Authors:  Robyn J Barst; Michael McGoon; Adam Torbicki; Olivier Sitbon; Michael J Krowka; Horst Olschewski; Sean Gaine
Journal:  J Am Coll Cardiol       Date:  2004-06-16       Impact factor: 24.094

10.  Noninvasive evaluation of pulmonary artery pressure during exercise by saline-enhanced Doppler echocardiography in chronic pulmonary disease.

Authors:  R B Himelman; M Stulbarg; B Kircher; E Lee; L Kee; N C Dean; J Golden; C L Wolfe; N B Schiller
Journal:  Circulation       Date:  1989-04       Impact factor: 29.690

View more
  27 in total

1.  Magnetic resonance imaging in pediatric pulmonary hypertension.

Authors:  Ayhan Pektas; Rana Olgunturk; Ayhan Cevik; Semiha Terlemez; Emre Kacar; Yusuf Ali Oner
Journal:  Tex Heart Inst J       Date:  2015-06-01

2.  Pulmonary arterial stiffness assessed by cardiovascular magnetic resonance imaging is a predictor of mild pulmonary arterial hypertension.

Authors:  Jordan C Ray; Charles Burger; Patricia Mergo; Robert Safford; Joseph Blackshear; Christopher Austin; DeLisa Fairweather; Michael G Heckman; Tonya Zeiger; Marcia Dubin; Brian Shapiro
Journal:  Int J Cardiovasc Imaging       Date:  2018-06-22       Impact factor: 2.357

3.  Magnetic resonance imaging to assess the effect of exercise training on pulmonary perfusion and blood flow in patients with pulmonary hypertension.

Authors:  Sebastian Ley; Christian Fink; Frank Risse; Nicola Ehlken; Christine Fischer; Julia Ley-Zaporozhan; Hans-Ulrich Kauczor; Hans Klose; Ekkehard Gruenig
Journal:  Eur Radiol       Date:  2012-08-12       Impact factor: 5.315

Review 4.  State-of-the-Art Imaging of the Lung for Connective Tissue Disease (CTD).

Authors:  Yoshiharu Ohno; Hisanobu Koyama; Takeshi Yoshikawa; Shinichiro Seki
Journal:  Curr Rheumatol Rep       Date:  2015-12       Impact factor: 4.592

Review 5.  Pulmonary hypertension: NHLBI Workshop on the Primary Prevention of Chronic Lung Diseases.

Authors:  Eric D Austin; Steven M Kawut; Mark T Gladwin; Steven H Abman
Journal:  Ann Am Thorac Soc       Date:  2014-04

6.  Cardiac Magnetic Resonance Imaging Evaluation of Neonatal Bronchopulmonary Dysplasia-associated Pulmonary Hypertension.

Authors:  Paul J Critser; Nara S Higano; Jean A Tkach; Emilia S Olson; David R Spielberg; Paul S Kingma; Robert J Fleck; Sean M Lang; Ryan A Moore; Michael D Taylor; Jason C Woods
Journal:  Am J Respir Crit Care Med       Date:  2020-01-01       Impact factor: 21.405

7.  Estimation of pulmonary vascular resistance in patients with pulmonary fibrosis by phase-contrast magnetic resonance imaging.

Authors:  Yuichiro Ayukawa; Sadayuki Murayama; Nanae Tsuchiya; Satomi Yara; Jiro Fujita
Journal:  Jpn J Radiol       Date:  2011-09-17       Impact factor: 2.374

8.  Pulmonary arterial hypertension: MR imaging-derived first-pass bolus kinetic parameters are biomarkers for pulmonary hemodynamics, cardiac function, and ventricular remodeling.

Authors:  Jan Skrok; Monda L Shehata; Stephen Mathai; Reda E Girgis; Ari Zaiman; James O Mudd; Danielle Boyce; Noah Lechtzin; João A C Lima; David A Bluemke; Paul M Hassoun; Jens Vogel-Claussen
Journal:  Radiology       Date:  2012-04-16       Impact factor: 11.105

Review 9.  Pulmonary Hypertension and Vascular Abnormalities in Bronchopulmonary Dysplasia.

Authors:  Peter M Mourani; Steven H Abman
Journal:  Clin Perinatol       Date:  2015-09-26       Impact factor: 3.430

10.  Cardiac MRI in pulmonary artery hypertension: correlations between morphological and functional parameters and invasive measurements.

Authors:  Jean-Philippe Alunni; Bruno Degano; Catherine Arnaud; Laurent Tétu; Nathalie Blot-Soulétie; Alain Didier; Philippe Otal; Hervé Rousseau; Valérie Chabbert
Journal:  Eur Radiol       Date:  2010-01-22       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.